New Delhi: India’s first indigenously-developed vaccine for prevention of cervical cancer will be launched here on Thursday.
Drugs Controller General of India (DCGI) last month granted market authorization to Serum Institute of India (SII) to manufacture the quadrivalent Human Papilloma Virus (HPV) vaccine.
Union Minister of Science and Technology Jitendra Singh will launch the vaccine at IIC Delhi, in the presence of SII CEO Adar Poonawalla, PTI reported.
According to officials, the qHPV vaccine CERVAVAC has shown robust antibody response which is nearly 1,000 times higher than the baseline against all targeted HPV types, and in all dose and age groups.
Cervical cancer is the second most common form of cancer among women in the 15-44 age group, after breast cancer.
Koraput: With the proposal to construct a cold storage of 50-ton capacity yet to take…
Bhubaneswar: Prime Minister Narendra Modi will review performance of the Mohan Majhi government in Odisha…
Paradip: All the 21 crew members of M V Devi cargo ship, which has been…
Bhubaneswar: The Ministry of Coal has successfully auctioned nine coal mines, including two in Odisha,…
Bhubaneswar: Badagada police on Wednesday rescued a four-year-old girl, who was allegedly sold by her…
Bhubaneswar: A photo of a man smoking cigarette on the premises of Shree Lingaraj Temple…
Bhubaneswar: The issue relating to purchase of land by Adani Group near Gandhamardan hills in…
Bhubaneswar: Over 1 lakh ghost ration card holders have been identified and removed from the…